Our mission is to help breast cancer patients live longer, better lives through earlier detection. We combine new deep learning methods, data science and radiology insights to help doctors find malignancies in mammograms. According to external clinical trial results, Kheiron’s deep learning technology achieves state-of-the-art malignancy detection support in breast cancer screening. European regulatory approval is expected shortly.
join us on our mission to revolutionise cancer diagnostics through the power of deep learning. You will be joining a company that truly believes that the power of AI working together with doctors and clinicians brings the best outcomes to patients. If you feel the same then please read more.